Sunday , December 17 2017
Home / Resources / Products / Liptruzet® – A Lipid-lowering Combination

Liptruzet® – A Lipid-lowering Combination

 
Liptruzet® – A Lipid-lowering Combination 

LiptruzetThe FDA has approved a new lipid-lowering combination tablet (Liptruzet) that includes atorvastatin and ezetimibe. The tablet is available as a once-daily tablet containing 10 mg of ezetimibe combined with 10, 20, 40, or 80 mg of atorvastatin, can be used to treat elevated LDL-cholesterol levels. Dosage range is 10/10 mg/day through 10/80 mg/day, with a recommended starting dose of 10/10 mg/day or 10/20 mg/day. For patients requiring a >55% reduction in LDL-C, the recommended starting dose is 10/40 mg/day.